The drug-coated balloons global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Drug-Coated Balloons Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The drug-coated balloons market size has grown rapidly in recent years. It will grow from $0.95 billion in 2023 to $1.1 billion in 2024 at a compound annual growth rate (CAGR) of 16.3%. The growth in the historic period can be attributed to increased cardiovascular disease burden, demand for minimally invasive procedures, prevalence of peripheral artery disease (pad), reducing restenosis rates, advancements in interventional cardiology..
The drug-coated balloons market size is expected to see rapid growth in the next few years. It will grow to $1.93 billion in 2028 at a compound annual growth rate (CAGR) of 15.0%. The growth in the forecast period can be attributed to increasing aging population, expansion of indications and applications, focus on outpatient and ambulatory care, integration with drug delivery innovations, global health initiatives.. Major trends in the forecast period include regulatory approvals for new formulations, focus on minimizing side effects, emergence of bioresorbable coatings, market expansion in emerging economies, patient-centric approaches..
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/drug-coated-balloons-global-market-report
Scope Of Drug-Coated Balloons Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Drug-Coated Balloons Market Overview
Market Drivers –
The rise in the prevalence of coronary artery disease is expected to propel the growth of the drug-coated balloons market going forward. Coronary artery disease (CAD) is a medical condition defined by the narrowing or obstruction of the coronary arteries, that feed blood to the heart muscle, leading to heart attacks. The drug-coated balloon is a medical device used in the treatment of coronary artery disease. The drug is released into the artery during the procedure to help prevent restenosis, which is the re-narrowing of the artery after angioplasty. For instance, in May 2023, according to the report published by the Centers for Disease Control and Prevention, a US-based national public health agency, the coronary heart disease, in United States, increased to 375,476 deaths in 2021 and about 1 in 20 adults aged 20 and older have coronary heart disease. Thus, the rise in the prevalence of coronary artery disease is expected to boost the drug-coated balloon market.
Market Trends –
Product innovations are a key trend gaining popularity in the drug-coated balloons market. Major companies operating in the drug-coated balloons market are focused on developing new technological and innovative solutions to strengthen their position in the market. For instance, in July 2021, Medtronic plc, a US-based provider of medical devices, launched the Prevail drug coated balloon (DCB) Catheter. This cutting-edge tool is used in percutaneous coronary intervention (PCI) operations to treat patients with coronary artery disease (CAD) who have blocked or constricted coronary arteries. It delivers focused therapy to the blockage location using paclitaxel, a medication with fast absorption. This enables effective treatment of many kinds of lesions, such as in-stent restenosis (ISR), small vascular disease, and de novo lesions.
The drug-coated balloons market covered in this report is segmented –
1) By Product: Drug-Coated Balloons For Peripheral Artery Disease, Drug-Coated Balloons For Coronary Artery Disease, Drug-Coated Balloons For Other Indications
2) By Drug Type: Paclitaxel, Sirolimus
3) By End User: Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers
Get an inside scoop of the drug-coated balloons market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=10829&type=smp
Regional Insights –
North America was the largest region in the global drug-coated balloons market in 2023, and is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-coated balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Key Companies –
Major companies operating in the drug-coated balloons market report are Acotec Scientific AG, AR Baltic Medical AB, B. Braun Melsungen AG, Becton Dickinson and Company, Biosensors International Group Ltd, Medtronic Inc., Koninklijke Philips N.V, Boston Scientific Corporation, Opto Circuits, Acrostak Corp., BioMed, Concept Medical, Cardionovum GmbH, Endocor GmbH, Hexacath Sverige, iVascular SLU, Minvasys SAS, MedAlliance, QT Vascular Ltd, RD Global-Invamed, Terumo Corporation, Biotronik, Cook Medical, Cordis Corporation, Abbott Laboratories, Surmodics Inc., Hexacath SAS, MicroPort, SurModics Inc., Orchestra BioMed
Table of Contents
1. Executive Summary
2. Drug-Coated Balloons Market Report Structure
3. Drug-Coated Balloons Market Trends And Strategies
4. Drug-Coated Balloons Market – Macro Economic Scenario
5. Drug-Coated Balloons Market Size And Growth
…..
27. Drug-Coated Balloons Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
